atorvastatin has been researched along with Age-Related Osteoporosis in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (35.29) | 29.6817 |
| 2010's | 8 (47.06) | 24.3611 |
| 2020's | 3 (17.65) | 2.80 |
| Authors | Studies |
|---|---|
| Shu, L; Tang, X; Xiong, Z; Yi, P; Zhang, C | 1 |
| Luo, W; Lv, Q; Xiao, Y; Xu, D; Xu, L; Yang, Q; Zhang, J; Zhou, Y | 1 |
| Boardman, HF; Janjua, SS; Javaid, KM; Johansen, A; Sami, A; Toh, LS | 1 |
| El-Nabarawi, N; El-Wakd, M; Salem, M | 1 |
| Hu, J; Huang, H; Huang, J; Tan, X; Xie, Y; Zou, P | 1 |
| Kaleağasıoğlu, F; Olcay, E; Onur, R | 1 |
| Rajamannan, NM | 1 |
| Murad, HA | 1 |
| Baloch, Z; Huo, Q; Ma, T; Shi, Q; Xie, Y; Zhou, H | 1 |
| Alexandre, JT; Brito, GA; Chaves, HV; Freitas, R; Furlaneto, F; Goes, P; Linhares, EV; Lisboa, MR; Marques, M; Martins, C; Ribeiro, I; Sousa, LH; Val, D | 1 |
| Abad, L; de Luis, D; Duenas-Laita, A; Gonzalez Sagredo, M; Pérez-Castrillón, JL; Sanz-Cantalapiedra, A; Vega, G | 1 |
| Abad, L; De Luis, D; Duenas-Laita, A; Pérez-Castrillón, JL; Sagredo, MG; Sanz-Cantalapiedra, A; Vega, G | 1 |
| Baytur, Y; Demir, BC; Gumuser, G; Inceboz, U; Ozbilgin, K; Uyar, Y | 1 |
| Gradosova, I; Hubena, S; Palicka, V; Svejkovska, K; Zivna, H; Zivny, P | 1 |
| Carmina, E; Castello, F; Di Fede, G; Mansueto, P; Rini, GB; Rizzo, M | 1 |
| Jadhav, SB; Jain, GK | 1 |
| Bielinska, A; Gluszko, P | 1 |
4 review(s) available for atorvastatin and Age-Related Osteoporosis
| Article | Year |
|---|---|
Meta-Analysis of the Efficacy and Safety of Alendronate Combined with Atorvastatin in the Treatment of Osteoporosis in Diabetes Mellitus.
Topics: Alendronate; Alkaline Phosphatase; Atorvastatin; Bone Density; Bone Density Conservation Agents; Diabetes Mellitus; Female; Humans; Osteocalcin; Osteoporosis; Osteoporosis, Postmenopausal | 2022 |
Statins and osteoporosis: myth or reality?
Topics: Anticholesteremic Agents; Atorvastatin; Bone Development; Female; Fractures, Bone; Heptanoic Acids; Humans; Osteoporosis; Pyrroles; Simvastatin | 2004 |
Statins and osteoporosis: new role for old drugs.
Topics: Animals; Atorvastatin; Bone and Bones; Clinical Trials as Topic; Drug Delivery Systems; Fatty Acids, Monounsaturated; Fluorobenzenes; Fluvastatin; Fractures, Bone; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Liver; Lovastatin; Osteogenesis; Osteoporosis; Pharmacokinetics; Pravastatin; Pyridines; Pyrimidines; Pyrroles; Quinolines; Rosuvastatin Calcium; Simvastatin; Sulfonamides | 2006 |
[Statins--are they potentially useful in rheumatology?].
Topics: Arthritis, Rheumatoid; Atorvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lupus Erythematosus, Systemic; Osteoporosis; Pyrroles; Rheumatic Diseases; Simvastatin; Treatment Outcome | 2007 |
13 other study(ies) available for atorvastatin and Age-Related Osteoporosis
| Article | Year |
|---|---|
Use of zoledronic acid in antiosteoporosis treatment is associated with a decreased blood lipid level in postmenopausal women with osteoporosis: a cohort study in China.
Topics: Atorvastatin; Bone Density Conservation Agents; Cholesterol, LDL; Cohort Studies; Female; Humans; Lipids; Osteoporosis; Postmenopause; Zoledronic Acid | 2022 |
Anti-osteoporosis medication dispensing by clinical commissioning groups in England - an ecological study of variability in practice and of the effect of the Covid-19 pandemic.
Topics: Aged; Atorvastatin; Bone Density Conservation Agents; COVID-19; England; Female; Hip Fractures; Humans; Male; Osteoporosis; Pandemics | 2023 |
Atorvastatin, a double weapon in osteoporosis treatment: an experimental and clinical study.
Topics: Absorptiometry, Photon; Administration, Oral; Aged; Animals; Atorvastatin; Bone Density; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Humans; Middle Aged; Osteoporosis; Ovariectomy; Rats; Rats, Wistar | 2017 |
Atorvastatin-loaded micelles with bone-targeted ligand for the treatment of osteoporosis.
Topics: Animals; Atorvastatin; Micelles; Osteoporosis; Polyethylene Glycols; Quality of Life; Rats; Tissue Distribution | 2017 |
Statins as potential agents for the prevention and treatment of osteoporosis.
Topics: Animals; Atorvastatin; Bone Density; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Osteoporosis; Rats; Simvastatin | 2018 |
Atorvastatin Attenuates Bone Loss and Aortic Valve Atheroma in LDLR Mice.
Topics: Animals; Anticholesteremic Agents; Aortic Valve; Aortic Valve Stenosis; Atherosclerosis; Atorvastatin; Calcinosis; Cholesterol, Dietary; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Macrophages; Mice; Osteogenesis; Osteoporosis; Plaque, Atherosclerotic; X-Ray Microtomography | 2015 |
L-Carnitine, but not coenzyme Q10, enhances the anti-osteoporotic effect of atorvastatin in ovariectomized rats.
Topics: Animals; Atorvastatin; Bone Density; Bone Density Conservation Agents; Carnitine; Dose-Response Relationship, Drug; Drug Synergism; Female; Osteoporosis; Ovariectomy; Radiography; Rats; Rats, Sprague-Dawley; Treatment Outcome; Ubiquinone | 2016 |
The effect of atorvastatin, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor (HMG-CoA), on the prevention of osteoporosis in ovariectomized rabbits.
Topics: Animals; Atorvastatin; Bone Density; Cell Line; Female; Femur; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Imaging, Three-Dimensional; Lumbar Vertebrae; Mice; Osteoporosis; Osteoprotegerin; Ovariectomy; Rabbits; RANK Ligand | 2017 |
Effects of Atorvastatin on Periodontitis of Rats Subjected to Glucocorticoid-Induced Osteoporosis.
Topics: Alveolar Bone Loss; Animals; Atorvastatin; Gene Expression; Glucocorticoids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Osteoporosis; Periodontitis; Rats; Rats, Wistar | 2016 |
Effect of the TNFalpha-308 G/A polymorphism on the changes produced by atorvastatin in bone mineral density in patients with acute coronary syndrome.
Topics: Absorptiometry, Photon; Acute Coronary Syndrome; Amino Acids; Anticholesteremic Agents; Atorvastatin; Bone Density; Calcium; Cholesterol; Dose-Response Relationship, Drug; Female; Femur Neck; Follow-Up Studies; Genotype; Heptanoic Acids; Humans; Magnesium; Male; Middle Aged; Osteocalcin; Osteoporosis; Phosphorus; Polymerase Chain Reaction; Polymorphism, Genetic; Pyrroles; Risk Factors; Triglycerides; Tumor Necrosis Factor-alpha | 2008 |
Atorvastatin and BMD in coronary syndrome. Role of Lys656Asn polymorphism of leptin receptor gene.
Topics: Acute Coronary Syndrome; Aged; Atorvastatin; Bone Density; Bone Remodeling; Female; Heptanoic Acids; Humans; Male; Middle Aged; Osteoporosis; Polymorphism, Genetic; Pyrroles; Receptors, Leptin | 2009 |
Comparative effects of risedronate, atorvastatin, estrogen and SERMs on bone mass and strength in ovariectomized rats.
Topics: Animals; Anticholesteremic Agents; Atorvastatin; Bone Density; Bone Density Conservation Agents; Clomiphene; Estrogens; Etidronic Acid; Female; Femur; Heptanoic Acids; Osteoporosis; Ovariectomy; Pyrroles; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Risedronic Acid; Selective Estrogen Receptor Modulators; Tibia | 2009 |
Protective effect of atorvastatin on bone tissue in orchidectomised male albino Wistar rats.
Topics: Animals; Atorvastatin; Biomarkers; Bone and Bones; Bone Density; Bone Density Conservation Agents; Calcium; Compressive Strength; Disease Models, Animal; Femur; Heptanoic Acids; Male; Orchiectomy; Osteoporosis; Pyrroles; Rats; Rats, Wistar; Tibia | 2012 |